To optimize a protocol for the steroid administration approach for idiopathic sudden sensorineural hearing loss (ISSNHL) in China.
Methods:
A questionnaire was distributed to otolaryngologists. The data on demographics, indications for first-line and salvage treatment, such as intratympanic administration of steroids (ITS) and postauricular steroids (PAS), and procedures were analyzed.
Results:
74 respondents used oral steroids, 112 used intravenous injections, 10 used ITS and 6 used PAS as a monotherapy for first-line treatment, and 135 used ITS or PAS in conjunction with oral or intravenous injection as a first-line treatment. Of the 249 respondents who used ITS, 97.19% adopted it as salvage therapy. The most commonly used steroid was 0.5 ml dexamethasone at 5 mg/ml and the most common side effect was pain. Of the 174 respondents who used PAS, 94.25% used it as salvage therapy. The most commonly used steroid was 0.5 ml methylprednisolone mixed with 0.5 ml lidocaine.
Conclusions:
The obtained data suggested that intravenous injection of steroids was the most popular treatment for ISSNHL and that ITS or PAS were used as a salvage treatment in China.
Chinese Journal of Otorhinolaryngology Head and Neck Surgery Editorial Committee. Sudden sensorineural hearing loss diagnosis and treatment guidelines. Chin J Otorhinolaryngol Head Neck Surg. 2015;50(6):443-447.
2.
TeranishiMKatayamaNUchidaYTominagaMNakashimaT.Thirty-year trends in sudden deafness from four nationwide epidemiological surveys in Japan. Acta Otolaryngol. 2007;127(12):1259-1265.
3.
StachlerRJChandrasekharSSArcherSM, et al. Clinical practice guideline: sudden hearing loss. Otolaryngol Head Neck Surg. 2012;146(3 Suppl):S1-S35.
4.
IwasakiSTakaiYOzekiHItoKKarinoSMurofushiT.Extent of lesions in idiopathic sudden hearing loss with vertigo: study using click and galvanic vestibular evoked myogenic potentials. Arch Otolaryngol Head Neck Surg. 2005;131(10):857-862.
5.
KimCSohnJHJangMU, et al. Ischemia as a potential etiologic factor in idiopathic unilateral sudden sensorineural hearing loss: analysis of posterior circulation arteries. Hear Res. 2016;331:144-151.
6.
MattoxDESimmonsFB.Natural history of sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol. 1977;86(4Pt 1): 463-480.
7.
Chinese sudden hearing loss multi-center clinical study group. Prospective clinical multi-center study on the treatment of sudden deafness with different typings in china. Chin J Otorhinolaryngol Head Neck Surg. 2013;48(5):355-361.
8.
ChoILeeHMChoiSW, et al. Comparison of two different treatment protocols using systemic and intratympanic steroids with and without hyperbaric oxygen therapy in patients with severe to profound idiopathic sudden sensorineural hearing loss: a randomized controlled trial. Audiol Neurootol. 2018;23(4):199-207.
9.
O’MalleyMRHaynesDS.Sudden hearing loss. Otolaryngol Clin North Am. 2008;41(3):633-649, x-xi.
10.
WilsonWRBylFMLairdN.The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study. Arch Otolaryngol. 1980;106(12): 772-776.
11.
ChenCYHalpinCRauchSD.Oral steroid treatment of sudden sensorineural hearing loss: a ten year retrospective analysis. Otol Neurotol. 2003;24(5):728-733.
12.
XenellisJPapadimitriouNNikolopoulosT, et al. Intratympanic steroid treatment in idiopathic sudden sensorineural hearing loss: a control study. Otolaryngol Head Neck Surg. 2006;134(6):940-945.
13.
RauchSD.Intratympanic steroids for sensorineural hearing loss. Otolaryngol Clin North Am. 2004;37(5):1061-1074.
14.
RauchSDHalpinCFAntonelliPJ, et al. Oral vs intratympanic corticosteroid therapy for idiopathic sudden sensorineural hearing loss: a randomized trial. J Am Med Assoc. 2011;305(20):2071-2079.
15.
SwachiaKSharmaDSinghJ. Efficacy of oral vs. intratympanic corticosteroids in sudden sensorineural hearing loss. J Basic Clin Physiol Pharmacol. 2016;27(4):371-377.
FitzgeraldDCMcGuireJF.Intratympanic steroids for idiopathic sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol. 2007;116(4):253-256.
18.
BattagliaABurchetteRCuevaR.Combination therapy (intratympanic dexamethasone + high-dose prednisone taper) for the treatment of idiopathic sudden sensorineural hearing loss. Otol Neurotol. 2008;29(4):453-460.
19.
GaoYLiuD.Combined intratympanic and systemic use of steroids for idiopathic sudden sensorineural hearing loss: a meta-analysis. Eur Arch Otorhinolaryngol. 2016;273(11):3699-3711.
20.
KimSHJungSYKimMGByunJYParkMSYeoSG.Comparison of steroid administration methods in patients with idiopathic sudden sensorineural hearing loss: a retrospective observational study. Clin Otolaryngol. 2015;40(3):183-190.
21.
ParkMKLeeCKParkKHLeeJDLeeCGLeeBD.Simultaneous versus subsequent intratympanic dexamethasone for idiopathic sudden sensorineural hearing loss. Otolaryngol Head Neck Surg. 2011;145(6):1016-1021.
22.
LiHFengGWangHFengY.Intratympanic steroid therapy as a salvage treatment for sudden sensorineural hearing loss after failure of conventional therapy: a meta-analysis of randomized, controlled trials. Clin Ther. 2015;37(1):178-187.
23.
YuanyuanJLishengYSenyaoMXSHongweiZ.Efficacy of postauricular methyprednisolone injection for refractory sudden hearing loss. Chin J Otol. 2014;12(3):452-454.
24.
LiJYuLXiaRGaoFLuoWJingY.Postauricular hypodermic injection to treat inner ear disorders: experimental feasibility study using magnetic resonance imaging and pharmacokinetic comparison. J Laryngol Otol. 2013;127(3):239-245.
25.
SuttonLSchartingerVUrlC, et al. Intratympanic steroid use for idiopathic sudden sensorineural hearing loss: current otolaryngology practice in Germany and Austria. Eur Arch Otorhinolaryngol. 2018;275(5):1103-1110.
26.
SuttonLMcElveenJTBrookesGShaidaALechnerM.Letter to the editor regarding comparison of 2 and 4 intratympanic steroid injections in the treatment of idiopathic sudden sensorineural hearing loss by Suzuki et al. Ann Otol Rhinol Laryngol. 2018;127(7):481-482.
27.
LechnerMSuttonLFergusonMAbbasYSandhuJShaidaA.Intratympanic steroid use for sudden sensorineural hearing loss: current otolaryngology practice. Ann Otol Rhinol Laryngol. 2019;128(6):490-502.
28.
ParnesLSSunAHFreemanDJ.Corticosteroid pharmacokinetic in the inner ear fluids: an animal study followed by clinical application. Laryngoscope. 1999;109(7Pt 2):1-17.
29.
BirdPABeggEJZhangMKeastATMurrayDPBalkanyTJ.Intratympanic versus intravenous delivery of methylprednisolone to cochlear perilymph. Otol Neurotol. 2007;28(8):1124-1130.
30.
MikulecAAPlontkeSKHartsockJJSaltAN.Entry of substances into perilymph through the bone of the otic capsule after intratympanic applications in guinea pigs: implications for local drug delivery in humans. Otol Neurotol. 2009;30(2):131-138.
31.
PlontkeSKBiegnerTKammererBDelabarUSaltAN.Dexamethasone concentration gradients along scala tympani after application to the round window membrane. Otol Neurotol. 2008;29(3):401-406.
32.
SaltANHartsockJPlontkeSLeBelCPiuF.Distribution of dexamethasone and preservation of inner ear function following intratympanic delivery of a gelbased formulation. Audiol Neurotol. 2011;16(5):323-335.
33.
Jing-JingLYuL-SRuiXFa-BaoGWen-LongLYuan-YuanJ.Feasibility study of inner ear drug delivery via post-auricular injection using 7.0 Tesla MRI. J Otol. 2012;2(10):144-148.
34.
YuanyuanJLishengYXingqiL.Compound betameth pharmacokinetics in plasma of guinea pig after postaurieal injection. J Audiol Speech Pathol. 2009;17(4):354-357.
35.
JingYYuLMaXShaoSZhengH.Efficacy of postauricular methylprednisolone injection for refractory sudden hearing loss. Chin J Otol. 2014;12(3):452-454.
36.
WangMFanZHouZZhangDWangH.Topical injection and systemic application of glucocorticoids in the treatment of idiopathic sudden sensorineural hearing loss by type. Chin J Otorhinolaryngol Head Neck Surg. 2014;49(1):11-15.
37.
ZhaoQWangYWangHXuPFengLLanN.Postaurieal injection of methylprednisolone as an auxiliary treatment for total hearing loss. Chin J Otol. 2015;13(4):712-714.
38.
XiaoqiYLi-ShengYXinM.Postaurieal injection of compound betamethasone to treat the intractable low-frequency sensorineural hearing loss. Chin J Otorhinolaryngol Head Neck Surg. 2007;42(11):814-816.
39.
ChandrasekharSTsai DoBSchwartzS, et al. Clinical practice guideline: sudden hearing loss (update). Otolaryngol Head Neck Surg. 2019;161:S1-S45.
40.
LeeJChoiSParkKParkHChooOChoungY.The efficiency of intratympanic dexamethasone injection as a sequential treatment after initial systemic steroid therapy for sudden sensorineural hearing loss. Eur Arch Otorhinolaryngol. 2011;268(6):833-839.
41.
LiPZengXYeJYangQZhangGLiY.Intratympanic methylprednisolone improves hearing function in refractory sudden sensorineural hearing loss: a control study. Audiol Neurootol. 2011;16(3):198-202.
42.
SpearSSchwartzS.Intratympanic steroids for sudden sensorineural hearing loss: a systematic review. Otolaryngol Head Neck Surg. 2011;145(4):534-543.
43.
ChouYChenPKuoIYuSWenYWuH.Comparison of intermittent intratympanic steroid injection and near-continual transtympanic steroid perfusion as salvage treatments for sudden sensorineural hearing loss. Laryngoscope. 2013;123(9):2264-2269.
44.
DallanIDe VitoAFattoriB, et al. Intratympanic methylprednisolone in refractory sudden hearing loss: a 27-patient case series with univariate and multivariate analysis. Otol Neurotol. 2010;31(1):25-30.
45.
Van WijckFStaeckerHLefebvreP. Topical steroid therapy using the Silverstein Microwick in sudden sensorineural hearing loss after failure of conventional treatment. Acta Otolaryngol. 2007;127(10):1012-1017.
46.
MoonILeeJKimJHongSLeeW.Intratympanic dexamethasone is an effective method as a salvage treatment in refractory sudden hearing loss. Otol Neurotol. 2011;32(9):1432-1436.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
